Home/Filings/4/0001209191-22-044874
4//SEC Filing

Warner Douglas J 4

Accession 0001209191-22-044874

CIK 0001828522other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 6:17 PM ET

Size

5.6 KB

Accession

0001209191-22-044874

Insider Transaction Report

Form 4
Period: 2022-08-08
Warner Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-08-08+618,160618,160 total
    Exercise: $0.90Exp: 2032-08-07Common Stock (618,160 underlying)
Footnotes (1)
  • [F1]The stock option vests 25% on August 8, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1
  • filerCIK 0001941311

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 6:17 PM ET
Size
5.6 KB